Clinical Trials
59 trialsADVANCED-2
Protara Therapeutics
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
enGene, Inc.
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Lepu Biopharma Co., Ltd.
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
University of Iowa
MAPAM-01
Institut Claudius Regaud
INTerpath-011
Merck Sharp & Dohme LLC
PUD
International Agency for Research on Cancer
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
University of Massachusetts, Boston
ADVANCED-3
Protara Therapeutics
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
BOND-003
CG Oncology, Inc.
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
ON-5001
OncoNano Medicine, Inc.
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
Astellas Pharma Inc
VoiceS
Insel Gruppe AG, University Hospital Bern
OHAI-NMIBC-01
First Affiliated Hospital of Wenzhou Medical University
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
Newish Technology (Beijing) Co., Ltd.
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
Children's Oncology Group
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices
Eastern Cooperative Oncology Group
ADVANCED-1
Protara Therapeutics
ADVANCED-1
Protara Therapeutics
HPV400
Tampere University Hospital
NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
Newish Technology (Beijing) Co., Ltd.
CORE-001
CG Oncology, Inc.
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Altor BioScience
Comparison of pCLE and EB in Gastric Lesion Diagnosis
Huazhong University of Science and Technology
Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Peking University First Hospital
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
University of Pittsburgh
PDT Plus Vitamin D3 for Anal Dysplasia
Abramson Cancer Center at Penn Medicine
LUSTIC
Medical University of Vienna
EHUD
Medical University of Vienna
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
H. Lee Moffitt Cancer Center and Research Institute
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
University of Arizona
BOND
CG Oncology, Inc.
A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102
Eisai Inc.
Erlotinib Prevention of Oral Cancer (EPOC)
M.D. Anderson Cancer Center
LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer
University of Pittsburgh
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
M.D. Anderson Cancer Center
RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)
Medical Enterprises Europe B.V.
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
Endo Pharmaceuticals
EMBARC-RF
Bioniche Life Sciences Inc.
Localization of Nonpalpable Breast Lesions
Rigshospitalet, Denmark
UH3
Barretos Cancer Hospital
Colposcopy in Detection of Oral Epithelial Dysplasia
Cairo University
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions
University Hospital Ostrava
CASSIS
McGill University
Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
Bioniche Life Sciences Inc.
Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia
Anandasabapathy, Sharmila, M.D.